Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115903084 | 11590308 | 4 | F | 2016 | 20160706 | 20151002 | 20160712 | EXP | US-PFIZER INC-2015260137 | PFIZER | 70.00 | YR | F | Y | 0.00000 | 20160712 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115903084 | 11590308 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 2X/DAY | L91467 | 21446 | 150 | MG | BID | ||||||
| 115903084 | 11590308 | 2 | C | XIFAXAN | RIFAXIMIN | 1 | UNK | 0 | |||||||||||
| 115903084 | 11590308 | 3 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 20 MG, DAILY | 0 | 20 | MG | |||||||||
| 115903084 | 11590308 | 4 | C | GLIPIZIDE. | GLIPIZIDE | 1 | 10 MG, 2X/DAY | 0 | 10 | MG | TABLET | BID | |||||||
| 115903084 | 11590308 | 5 | C | LANTUS | INSULIN GLARGINE | 1 | UNK | 0 | |||||||||||
| 115903084 | 11590308 | 6 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | UNK | 0 | |||||||||||
| 115903084 | 11590308 | 7 | C | NADOLOL. | NADOLOL | 1 | 40 MG, DAILY (80MG, ONE HALF FOR 40 MG DAILY) | 0 | 40 | MG | |||||||||
| 115903084 | 11590308 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 20 MG, DAILY | 0 | 20 | MG | |||||||||
| 115903084 | 11590308 | 9 | C | FLORANEX | LACTOBACILLUS ACIDOPHILUSLACTOBACILLUS DELBRUECKII SUBSP. BULGARICUS | 1 | UNK | 0 | |||||||||||
| 115903084 | 11590308 | 10 | C | LACTULOSE. | LACTULOSE | 1 | UNK | 0 | |||||||||||
| 115903084 | 11590308 | 11 | C | METFORMIN HCL | METFORMIN HYDROCHLORIDE | 1 | 1000 MG, 2X/DAY | 0 | 1000 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115903084 | 11590308 | 1 | Pain in extremity |
| 115903084 | 11590308 | 11 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115903084 | 11590308 | HO |
| 115903084 | 11590308 | OT |
| 115903084 | 11590308 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115903084 | 11590308 | Asthenia | |
| 115903084 | 11590308 | Belligerence | |
| 115903084 | 11590308 | Blood glucose increased | |
| 115903084 | 11590308 | Blood pressure decreased | |
| 115903084 | 11590308 | Fall | |
| 115903084 | 11590308 | Fluid retention | |
| 115903084 | 11590308 | Haematochezia | |
| 115903084 | 11590308 | Haemoglobin decreased | |
| 115903084 | 11590308 | Haemorrhage | |
| 115903084 | 11590308 | Intentional product misuse | |
| 115903084 | 11590308 | Liver disorder | |
| 115903084 | 11590308 | Malaise | |
| 115903084 | 11590308 | Mental impairment | |
| 115903084 | 11590308 | Platelet count decreased | |
| 115903084 | 11590308 | Renal failure | |
| 115903084 | 11590308 | Sepsis | |
| 115903084 | 11590308 | Swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |